These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


107 related items for PubMed ID: 4053406

  • 1. Liquid chromatographic determination of inhibition of monoamine oxidase activity in platelet rich plasma of depressed patients treated with phenelzine.
    Gupta RN, Steiner M.
    Clin Chim Acta; 1985 Oct 31; 152(1-2):63-9. PubMed ID: 4053406
    [Abstract] [Full Text] [Related]

  • 2. Determination of unconjugated 3-methoxy-4-hydroxyphenylglycol by liquid chromatography for monitoring inhibition of monoamine oxidase activity in plasma.
    Gupta RN, Steiner M, Lew M.
    Clin Chem; 1987 Nov 31; 33(11):2078-80. PubMed ID: 3677382
    [Abstract] [Full Text] [Related]

  • 3. Prediction of response to nortriptyline and phenelzine by platelet MAO activity.
    Georgotas A, McCue RE, Friedman E, Cooper T.
    Am J Psychiatry; 1987 Mar 31; 144(3):338-40. PubMed ID: 3826434
    [Abstract] [Full Text] [Related]

  • 4. Platelet monoamine oxidase inhibition as a potential indicator of favorable response to MAOI's in geriatric depressions.
    Georgotas A, Mann J, Friedman E.
    Biol Psychiatry; 1981 Oct 31; 16(10):997-1001. PubMed ID: 7306621
    [No Abstract] [Full Text] [Related]

  • 5. Liquid chromatographic determination of urinary metanephrines after pre-column oxidation to vanillin.
    Gupta RN, Pickersgill R, McIntyre M.
    Clin Chim Acta; 1983 Dec 15; 135(2):143-50. PubMed ID: 6652923
    [Abstract] [Full Text] [Related]

  • 6. Relationship between response to phenelzine and MAO inhibition in a clinical trial of phenelzine, amitriptyline and placebo.
    Raft D, Davidson J, Wasik J, Mattox A.
    Neuropsychobiology; 1981 Dec 15; 7(3):122-6. PubMed ID: 7231652
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of platelet monoamine oxidase in depressed subjects treated with phenelzine.
    Davidson J, McLeod MN, White HL.
    Am J Psychiatry; 1978 Apr 15; 135(4):470-2. PubMed ID: 345826
    [Abstract] [Full Text] [Related]

  • 8. Platelet MAO inhibition, urinary MHPG, and leukocyte beta-adrenergic receptors in depressed patients treated with phenelzine.
    Sharma RP, Janicak PG, Javaid JI, Pandey GN, Gierl B, Davis JM.
    Am J Psychiatry; 1990 Oct 15; 147(10):1318-21. PubMed ID: 2169208
    [Abstract] [Full Text] [Related]

  • 9. Acetylation phenotype, platelet monoamine oxidase inhibition, and the effectiveness of phenelzine in depression.
    Davidson J, McLeod MN, Blum MR.
    Am J Psychiatry; 1978 Apr 15; 135(4):467-9. PubMed ID: 345825
    [Abstract] [Full Text] [Related]

  • 10. Factors affecting the delay of antidepressant effect in responders to nortriptyline and phenelzine.
    Georgotas A, McCue RE, Cooper TB, Nagachandran N, Friedhoff A.
    Psychiatry Res; 1989 Apr 15; 28(1):1-9. PubMed ID: 2662234
    [Abstract] [Full Text] [Related]

  • 11. Plasma levels of catecholamines and dihydroxyphenylglycol during antidepressant drug treatment.
    Robinson DS, Johnson GA, Nies A, Corcella J, Cooper TB, Albright D, Howard D.
    J Clin Psychopharmacol; 1983 Oct 15; 3(5):282-7. PubMed ID: 6355207
    [Abstract] [Full Text] [Related]

  • 12. Platelet and plasma amine oxidase inhibition and urinary amine excretion changes during phenelzine treatment.
    Murphy DL, Brand E, Goldman T, Baker M, Wright C, van Kammen D, Gordon E.
    J Nerv Ment Dis; 1977 Feb 15; 164(2):129-34. PubMed ID: 836485
    [Abstract] [Full Text] [Related]

  • 13. Assay of platelet monoamine oxidase in whole blood.
    van Kempen GM, van Brussel JL, Pennings EJ.
    Clin Chim Acta; 1985 Dec 31; 153(3):197-202. PubMed ID: 4075526
    [Abstract] [Full Text] [Related]

  • 14. Resistant geriatric depressions and therapeutic response to monoamine oxidase inhibitors.
    Georgotas A, Friedman E, McCarthy M, Mann J, Krakowski M, Siegel R, Ferris S.
    Biol Psychiatry; 1983 Feb 31; 18(2):195-205. PubMed ID: 6830930
    [Abstract] [Full Text] [Related]

  • 15. Monoamine oxidase inhibitors and whole blood, platelet and plasma monoamine oxidase.
    Marshall EF.
    Prog Neuropsychopharmacol; 1979 Feb 31; 3(4):391-3. PubMed ID: 400994
    [Abstract] [Full Text] [Related]

  • 16. Further studies on the endogenous inhibitor of monoamine oxidase in schizophrenic plasma.
    Vogel WH, Ladman RK, Berrettini WH.
    Schizophr Bull; 1980 Feb 31; 6(2):232-4. PubMed ID: 7375855
    [Abstract] [Full Text] [Related]

  • 17. Bulimia and monoamine oxidase inhibitors: a predictor study.
    Hardy BW, Waller DA, Orsulak PJ.
    Tex Med; 1985 Oct 31; 81(10):39-42. PubMed ID: 3904070
    [No Abstract] [Full Text] [Related]

  • 18. Platelet MAO-B and endogenous MAO-A inhibitory activity in depressed patients: stability with electroconvulsive treatment.
    Moriearty PL, Herrick C, Shafey M, Bornstein P, Becker RE.
    Biol Psychiatry; 1987 Sep 31; 22(9):1155-8. PubMed ID: 3651533
    [No Abstract] [Full Text] [Related]

  • 19. Acetylator status and inhibition of platelet monoamine oxidase following treatment with phenelzine.
    Yates CM, Loudon JB.
    Psychol Med; 1979 Nov 31; 9(4):777-9. PubMed ID: 515276
    [No Abstract] [Full Text] [Related]

  • 20. MAO inhibition and clinical response in depressed patients treated with phenelzine.
    Bresnahan DB, Pandey GN, Janicak PG, Sharma R, Boshes RA, Chang SS, Gierl BL, Davis JM.
    J Clin Psychiatry; 1990 Feb 31; 51(2):47-50. PubMed ID: 2298705
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.